Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NHOIY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN117337196A Compound56
|
|||||
| Synonyms |
SCAPDL1xSCACD47-20kPEG-3 (Val-Cit-PAB-DEA-Duo-DM)
Click to Show/Hide
|
|||||
| Organization |
Shenzhen Enduring Biotech Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1
|
|||||
| Structure |
|
|||||
| Antibody Name |
SCAPDL1xSCACD47
|
Antibody Info | ||||
| Antigen Name |
Programmed cell death ligand 1 (PD-L1); Leukocyte surface antigen CD47 (CD47)
|
Antigen Info | ||||
| Payload Name |
Duocarmycin DM
|
Payload Info | ||||
| Linker Name |
Mal-20kPEG-3 (Val- Cit-PAB-DEA-Duo)
|
Linker Info | ||||
| Conjugate Type |
Site-specific bioconjugation at Trastuzumab-Lys248-thiol
|
|||||
| Combination Type |
Mal-20kPEG-3 (Val-Cit-PAB-DEA-Duo-DM)
|
|||||